Lonza, a provider of pharmaceutical, biotech and specialty ingredients products, has partnered with Alliance Global (AGBL) to expand its product offerings into Africa
Alliance Global Group of companies is a biomedical gateway in the Middle East, Africa, and Asia.
“Establishing this partnership with AGBL enables Lonza Bioscience brands to penetrate into the African markets. The Lonza products will offer AGBL customers some of the best bioscience products, services and testing solutions available,” emphasised Tanja Brauer, head of sales EMEA at Lonza.
“Our partnership with Lonza will complement the AGBL range of products and further support our customers in the bioresearch, pharmaceutical and biotech markets,” said Jack Farah, product manager cell and molecular biology division at AGBL.
